Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database

References

• GuariguataLWhitingDRHambletonIBeagleyJLinnenkampUShawJEGlobal estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Res Clin Pract201410313714924630390
   PubMed Web of Science ®Google Scholar
• Mandereau-BrunoLDenisPFagot-CampagnaAFosse-EdorhSPrevalence of people pharmacologically treated for diabetes and territorial variations in France in 2012Bull Epidémiol Hebd201430–31493499
   Google Scholar
• AmielSADixonTMannRJamesonKHypoglycaemia in type 2 diabetesDiabet Med20082524525418215172
   PubMed Web of Science ®Google Scholar
• BronMMarynchenkoMYangHYuAPWuEQHypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugsPostgrad Med201212412413222314122
   PubMed Web of Science ®Google Scholar
• BudnitzDSLovegroveMCShehabNRichardsCLEmergency hospitalizations for adverse drug events in older AmericansN Engl J Med20113652002201222111719
   PubMed Web of Science ®Google Scholar
• MajumdarSRHemmelgarnBRLinMMcBrienKMannsBJTonelliMHypoglycemia associated with hospitalization and adverse events in older people: population-based cohort studyDiabetes Care2013363585359024089536
   PubMed Web of Science ®Google Scholar
• LipskaKJRossJSWangYNational trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011JAMA Intern Med20141741116112424838229
   PubMed Web of Science ®Google Scholar
• AhrenBAre sulfonylureas less desirable than DPP-4 inhibitors as add-on to metformin in the treatment of type 2 diabetes?Curr Diab Rep201111839021243448
   PubMed Web of Science ®Google Scholar
• DejagerSSchweizerAMinimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes managementDiabetes Ther20112516622127800
   PubMedGoogle Scholar
• HalimiSRaccahDSchweizerADejagerSRole of vildagliptin in managing type 2 diabetes mellitus in the elderlyCurr Med Res Opin2010261647165620441397
   PubMed Web of Science ®Google Scholar
• SchweizerADejagerSFoleyJEShaoQKothnyWClinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trialsDiabetes Obes Metab201113556421114604
   PubMed Web of Science ®Google Scholar
• DejagerSSchweizerAIncretin therapies in the management of patients with type 2 diabetes mellitus and renal impairmentHosp Pract (1995)20124072122615074
   PubMedGoogle Scholar
• CharbonnelBSchweizerADejagerSCombination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?Hosp Pract (1995)2013419310723680741
   PubMedGoogle Scholar
• AhrénBSchweizerADejagerSVildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetesJ Clin Endocrinol Metab2009941236124319174497
   PubMed Web of Science ®Google Scholar
• GökeBGallwitzBErikssonJHellqvistAGause-NilssonID1680C00001 InvestigatorsSaxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trialInt J Clin Pract2010641619163120846286
   PubMed Web of Science ®Google Scholar
• MatthewsDRDejagerSAhrénBVildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year studyDiabetes Obes Metab20101278078920649630
   PubMed Web of Science ®Google Scholar
• NauckMAMeiningerGShengDTerranellaLSteinPPSitagliptin Study 024 GroupEfficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trialDiabetes Obes Metab2007919420517300595
   PubMed Web of Science ®Google Scholar
• TuppinPde RoquefeuilLWeillARicordeauPMerlièreYFrench national health insurance information system and the permanent beneficiaries sampleRev Epidemiol Sante Publique20105828629020598822
   PubMed Web of Science ®Google Scholar
• BlinPLassalleRDureau-PourninCInsulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance DatabaseDiabetologia20125564465322222504
   PubMed Web of Science ®Google Scholar
• SabouretPDepret-BixioLCotteFEMariePBediraNBlinPSex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) DatabaseClin Res Cardiol201410388789324830515
   PubMed Web of Science ®Google Scholar
• Haute Autorité de Santé Avis de la Comission de TransparenceGalvus, 10 Décembre 2008 Available from: www.has-sante.fr/portail/plugins/ModuleXitiKLEE/types/FileDocument/doXiti.jsp?id=c_749360Accessed June 8, 2015 French
   Google Scholar
• LipskaKJWartonEMHuangESHbA1c and risk of severe hypoglycemia in type 2 diabetes: the diabetes and aging studyDiabetes Care2013363535354223900589
   PubMed Web of Science ®Google Scholar
• KrobotKJFerranteSADaviesMJLower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) valueCurr Med Res Opin2012281281128722697277
   PubMed Web of Science ®Google Scholar
• AhrénBFoleyJEDejagerSHigher risk of hypoglycemia with glimepiride versus vildagliptin in patients with type 2 diabetes is not driven by high doses of glimepiride: divergent patient susceptibilities?Diabetes Ther2014545946925230877
   PubMed Web of Science ®Google Scholar
• PenfornisABourdel-MarchassonIQuereSDejagerSReal-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS studyDiabetes Metab20123855055722996038
   PubMed Web of Science ®Google Scholar
• SimonDDetournayBEschwegeEReal-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS studyDiabetes Ther2014520722424729158
   PubMedGoogle Scholar
• MathieuCBarnettAHBrathHEffectiveness and tolerability of second-line therapy with vildagliptin vs other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE)Int J Clin Pract20136794795623961850
   PubMed Web of Science ®Google Scholar
• FarngrenJPerssonMSchweizerAFoleyJEAhrénBGlucagon dynamics during hypoglycemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetesDiabetes Obes Metab20141681281824612221
   PubMed Web of Science ®Google Scholar
• FarngrenJPerssonMSchweizerAFoleyJEAhrénBVildagliptin reduces glucagon during hyperglycemia and sustains glucagon counter-regulation during hypoglycemia in type 1 diabetesJ Clin Endocrinol Metab2012973799380622855332
   PubMed Web of Science ®Google Scholar
• LiatisSMylonaMKalopitaSHypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitalsDiabetes Metab20154112613125468446
   PubMed Web of Science ®Google Scholar
• NelsonJMDufrauxKCookPFThe relationship between glycemic control and falls in older adultsJ Am Geriatr Soc2007552041204417971138
   PubMed Web of Science ®Google Scholar
• WhitmerRAKarterAJYaffeKQuesenberryCPJrSelbyJVHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitusJAMA20093011565157219366776
   PubMed Web of Science ®Google Scholar
• HsuPFSungSHChengHMAssociation of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based studyDiabetes Care20133689490023223349
   PubMed Web of Science ®Google Scholar
• StahnAPistroschFGanzXRelationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmiasDiabetes Care20143751652024041680
   PubMed Web of Science ®Google Scholar
• McCoyRGVan HoutenHKZiegenfussJYShahNDWermersRASmithSAIncreased mortality of patients with diabetes reporting severe hypoglycemiaDiabetes Care2012351897190122699297
   PubMed Web of Science ®Google Scholar
• MorganCLMukherjeeJJenkins-JonesSHoldenSECurrieCJCombination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortalityDiabetes Obes Metab20141697798324762119
   PubMed Web of Science ®Google Scholar
• FulcherGSingerJCastañedaRThe psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveysJ Med Econ20141775176125061766
   PubMedGoogle Scholar
• BarendseSSinghHFrierBMSpeightJThe impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: a narrative reviewDiabet Med20122929330221838763
   PubMed Web of Science ®Google Scholar
• WildDvon MaltzahnRBrohanEChristensenTClausonPGonder-FrederickLA critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient educationPatient Educ Couns200768101517582726
   PubMed Web of Science ®Google Scholar
• BrodMWoldenMChristensenTBushnellDMUnderstanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilizationValue Health2013161140114924326167
   PubMed Web of Science ®Google Scholar
• HillHAKleinbaumDGBias in Observational StudiesWiley StatsRef Statistics Reference Online2014 Available from: http://onlinelibrary.wiley.com/doi/10.1002/9781118445112.stat05111/abstractAccessed June 10, 2015
   Google Scholar
• CariouBFontainePEschwegeEFrequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG studyDiabetes Metab20154111612525465273
   PubMed Web of Science ®Google Scholar